Ad image
Uncategorized

Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says

admin
admin
0 Min Read

Liraglutide is sold under the brand names Saxenda and Victoza, and sales are declining as blockbuster GLP-1s Ozempic and Wegovy skyrocket in demand.

You Might Also Like

Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says

GM and Hyundai agree to explore collaboration on vehicles and manufacturing to reduce capital spending

Why the LA Rams are worth $2 billion more than the LA Chargers

Peloton shares rise more than 15% as turnaround plan takes hold, losses shrink

Airbus Ventures launches $155 million fund focused on deep tech, including space

Share This Article
Previous Article At the year’s biggest air show, Boeing and Airbus orders were muted. Supply chain worries were not
Next Article Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
Leave a comment

Stay Connected

- Advertisement -

Latest News

Charter rolls out new Spectrum pricing and internet speeds, aims to ‘be a better service operator’
Uncategorized
Boeing freezes hiring in sweeping cost cuts as it grapples with factory worker strike
Uncategorized
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
Uncategorized
DirecTV, Disney reach deal to end blackout in time for college football
Uncategorized
TODAYNEO